DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Brown JR, Byrd JC, Coutre SE. et al.
Idelalisib, an inhibitor of phosphatidylinositol 3- kinase p110delta, for relapsed/refractory chronic lymphocytic leukemia.
Blood 2014;
123: 3390-3397
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.